Brookdale Senior Living (BKD)
(Delayed Data from NYSE)
$6.79 USD
-0.12 (-1.74%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $6.80 +0.01 (0.15%) 5:02 PM ET
2-Buy of 5 2
B Value D Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
BKD 6.79 -0.12(-1.74%)
Will BKD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BKD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BKD
Brookdale Senior (BKD) Sees Y/Y Increase in Q1 Occupancy Levels
Brookdale (BKD) February 2024 Weighted Average Occupancy Rises
BKD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Brookdale Senior's (BKD) Q4 Loss Widens, Shares Drop 13%
Tenet Healthcare (THC) Q4 Earnings Beat on Hospital Operations
Cigna (CI) Q4 Earnings Beat on Membership Growth, Dividend Up
Other News for BKD
Neutral Outlook with Revised Price Objective for Brookdale Senior Living Amidst Occupancy Gains and Financial Structure Concerns
Brookdale Announces Date of First Quarter 2024 Earnings Release and Conference Call
Bruker Corp Enhances Portfolio with NanoString Acquisition
Commit To Purchase Brookdale Senior Living At $5, Earn 11.8% Annualized Using Options
RBC Capital Remains a Buy on Brookdale Senior Living (BKD)